J7668 Metaproterenol non-comp con

Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams

• Medicare coverage: Special coverage instructions apply
• Status: active (July 2026 file)
• MUE: max 0 units per day (practitioner), rationale: Drug discontinued